vs
Side-by-side financial comparison of OneSpan Inc. (OSPN) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
OneSpan Inc. is the larger business by last-quarter revenue ($65.9M vs $39.6M, roughly 1.7× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 17.5%, a 18.4% gap on every dollar of revenue. On growth, OneSpan Inc. posted the faster year-over-year revenue change (4.1% vs -10.9%). Over the past eight quarters, OneSpan Inc.'s revenue compounded faster (4.0% CAGR vs -15.0%).
OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
OSPN vs SBC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $65.9M | $39.6M |
| Net Profit | $11.6M | $14.2M |
| Gross Margin | 73.6% | 73.1% |
| Operating Margin | 22.5% | 32.5% |
| Net Margin | 17.5% | 35.9% |
| Revenue YoY | 4.1% | -10.9% |
| Net Profit YoY | — | 117.2% |
| EPS (diluted) | $0.39 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $65.9M | — | ||
| Q4 25 | $62.9M | $39.6M | ||
| Q3 25 | $57.1M | $43.4M | ||
| Q2 25 | $59.8M | $43.4M | ||
| Q1 25 | $63.4M | $47.3M | ||
| Q4 24 | $61.2M | $44.4M | ||
| Q3 24 | $56.2M | $53.1M | ||
| Q2 24 | $60.9M | $53.1M |
| Q1 26 | $11.6M | — | ||
| Q4 25 | $43.5M | $14.2M | ||
| Q3 25 | $6.5M | $12.8M | ||
| Q2 25 | $8.3M | $2.5M | ||
| Q1 25 | $14.5M | $21.5M | ||
| Q4 24 | $28.8M | $6.5M | ||
| Q3 24 | $8.3M | $2.8M | ||
| Q2 24 | $6.6M | $18.5M |
| Q1 26 | 73.6% | — | ||
| Q4 25 | 73.6% | 73.1% | ||
| Q3 25 | 73.6% | 70.6% | ||
| Q2 25 | 73.5% | 69.2% | ||
| Q1 25 | 74.3% | 79.7% | ||
| Q4 24 | 74.0% | 76.3% | ||
| Q3 24 | 73.9% | 81.5% | ||
| Q2 24 | 66.2% | 74.2% |
| Q1 26 | 22.5% | — | ||
| Q4 25 | 19.9% | 32.5% | ||
| Q3 25 | 14.4% | 36.6% | ||
| Q2 25 | 17.6% | 33.6% | ||
| Q1 25 | 27.1% | 51.1% | ||
| Q4 24 | 19.3% | 10.6% | ||
| Q3 24 | 20.0% | 26.1% | ||
| Q2 24 | 12.5% | 51.4% |
| Q1 26 | 17.5% | — | ||
| Q4 25 | 69.2% | 35.9% | ||
| Q3 25 | 11.4% | 29.6% | ||
| Q2 25 | 13.9% | 5.7% | ||
| Q1 25 | 22.9% | 45.4% | ||
| Q4 24 | 47.1% | 14.7% | ||
| Q3 24 | 14.7% | 5.3% | ||
| Q2 24 | 10.8% | 34.8% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $1.13 | $0.15 | ||
| Q3 25 | $0.17 | $0.12 | ||
| Q2 25 | $0.21 | $0.02 | ||
| Q1 25 | $0.37 | $0.21 | ||
| Q4 24 | $0.73 | $0.05 | ||
| Q3 24 | $0.21 | $0.03 | ||
| Q2 24 | $0.17 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.8M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $272.0M | $248.3M |
| Total Assets | $383.1M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $49.8M | — | ||
| Q4 25 | $70.5M | $164.1M | ||
| Q3 25 | $85.6M | $127.4M | ||
| Q2 25 | $92.9M | $152.7M | ||
| Q1 25 | $105.2M | $132.1M | ||
| Q4 24 | $83.2M | $125.0M | ||
| Q3 24 | $77.5M | $137.4M | ||
| Q2 24 | $63.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — |
| Q1 26 | $272.0M | — | ||
| Q4 25 | $271.8M | $248.3M | ||
| Q3 25 | $238.3M | $248.0M | ||
| Q2 25 | $242.5M | $244.6M | ||
| Q1 25 | $231.1M | $226.4M | ||
| Q4 24 | $212.5M | $195.1M | ||
| Q3 24 | $194.6M | $205.0M | ||
| Q2 24 | $178.6M | $8.8M |
| Q1 26 | $383.1M | — | ||
| Q4 25 | $397.7M | $380.4M | ||
| Q3 25 | $343.5M | $321.4M | ||
| Q2 25 | $357.1M | $315.3M | ||
| Q1 25 | $333.8M | $284.6M | ||
| Q4 24 | $338.7M | $266.1M | ||
| Q3 24 | $289.3M | $296.5M | ||
| Q2 24 | $286.9M | $19.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | 2.44× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $28.2M | — | ||
| Q4 25 | $12.6M | $52.0M | ||
| Q3 25 | $11.3M | $-20.9M | ||
| Q2 25 | $6.2M | $-8.3M | ||
| Q1 25 | $29.4M | $1.9M | ||
| Q4 24 | $12.4M | $-7.3M | ||
| Q3 24 | $14.0M | $5.0M | ||
| Q2 24 | $2.3M | $19.2M |
| Q1 26 | — | — | ||
| Q4 25 | $9.6M | $51.2M | ||
| Q3 25 | $8.8M | $-20.9M | ||
| Q2 25 | $4.4M | $-8.6M | ||
| Q1 25 | $27.7M | $1.7M | ||
| Q4 24 | $10.5M | $-7.9M | ||
| Q3 24 | $12.0M | $4.6M | ||
| Q2 24 | $26.0K | $18.3M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 129.3% | ||
| Q3 25 | 15.4% | -48.3% | ||
| Q2 25 | 7.3% | -19.9% | ||
| Q1 25 | 43.8% | 3.5% | ||
| Q4 24 | 17.1% | -17.8% | ||
| Q3 24 | 21.4% | 8.7% | ||
| Q2 24 | 0.0% | 34.5% |
| Q1 26 | — | — | ||
| Q4 25 | 4.7% | 2.0% | ||
| Q3 25 | 4.4% | 0.1% | ||
| Q2 25 | 3.1% | 0.7% | ||
| Q1 25 | 2.6% | 0.5% | ||
| Q4 24 | 3.2% | 1.3% | ||
| Q3 24 | 3.5% | 0.8% | ||
| Q2 24 | 3.7% | 1.6% |
| Q1 26 | 2.44× | — | ||
| Q4 25 | 0.29× | 3.66× | ||
| Q3 25 | 1.74× | -1.63× | ||
| Q2 25 | 0.75× | -3.39× | ||
| Q1 25 | 2.02× | 0.09× | ||
| Q4 24 | 0.43× | -1.12× | ||
| Q3 24 | 1.69× | 1.77× | ||
| Q2 24 | 0.35× | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OSPN
| Product and license | $35.5M | 54% |
| Services and other | $30.4M | 46% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
